Health

Australians with non–small cell lung cancer (NSCLC) using tyrosine kinase inhibitors (TKIs) are invited to share their lived experience in
International Lung Cancer Awareness Month why not be part of a 30–60 minute interview to help with ALK+ research.
Short call to action referencing International Lung Cancer Awareness Month and the 30–60 minute interview.
Scroll to Top